🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06513780
Recruiting Observational

A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation

NCT06513780 · tracked via the Priya Life Science China tracker
Sponsor
Ru-zhou Cai
Phase
Observational
Started
2016-01-01
Last updated
2025-09-18

Condition(s) studied

Portal Vein Thrombosis

Investigational drug(s) / intervention(s)

Observation

Observation: No intervention were made.

Study summary

The goal of this observational study is to investigate the correlation between portal vein thrombosis (PVT) and the prognosis of liver transplantation. The main questions it aims to address are:

What is the prevalence of PVT? What are the risk factors associated with PVT? What is the prognostic impact of preoperative PVT on liver transplantation?

Participants are divided into two groups: the PVT group and the non-PVT group. The investigators will comparatively analyze the data of both groups, estimate the prevalence and risk factors of PVT, construct a predictive model for PVT that is applicable in clinical settings, and clarify the prognostic effects of PVT.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Liver transplantation recipients 2. Aged 18 years or older. Exclusion Criteria: 1. Retransplantation 2. Multi-organ transplantation 3. Portal vein tumor thrombus

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Friendship Hospital, Capital Medical University Beijing China Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06513780 on ClinicalTrials.gov ↗ ← All trials in China